10
total announcements
CAMLINFINE.NS · 15 min delayed
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited has informed the Exchange about the dispatch of notice of its 33rd Annual General Meeting through video conferencing.
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited has informed the Exchange about letters sent to Shareholders regarding the Annual Report 2025-26 and the 33rd Annual General Meeting (AGM) scheduled for August 11, 2026.
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 11, 2026, to consider and adopt audited financial statements for FY 2025-26, re-appointment of directors, and other business.
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited has informed the Exchange about a copy of newspaper publication related to the 33rd Annual General Meeting of the company.
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited has completed the simplified cash tender offer for the remaining shares of Vinpai, acquiring 95.41% of the share capital and 91.46% of the theoretical voting rights. The company will not request a squeeze-out procedure for Vinpai shares from the Euronext Growth Paris market.
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2026.
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited has informed the Exchange about the resignation of a Director/KMP/SMP.
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited has informed the Exchange regarding the resignation of Mr. Anvarhusen Bilakhiya as Senior Management Personnel of the company, effective July 7, 2026, due to personal commitments.
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited has received a declaration from Ashish Dandekar, the promoter and promoter group of the company, under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The declaration states that the promoter group has not made any encumbrance on the shares of the company held by them, directly or indirectly, other than those already disclosed during the financial year ended March 31, 2026.
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited has informed the Exchange about an update on an analyst/institutional investor meeting, stating that company officials interacted with investors/analysts on July 1, 2026, in Mumbai, discussing publicly available information and no unpublished price-sensitive information was shared.